Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of the Effect of add-on Sulforaphane in Treatment of Schizophrenia

NCT02880462 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT02880462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02880462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of the Effect of add-on Sulforaphane in Treatment of Schizophrenia
Lead sponsor
Central South University
Phase
Phase 2
Overall status
Completed
Start date
December 26, 2016
Completion date
May 20, 2019
Enrollment
172 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia